
A company that assesses DNA is dealing with the repercussions of public outcry after a data protection lawyer highlighted a …

The genetic testing firm 23andMe is seeking to raise $150 million in order to move into its own drug development …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

